2026-05-25T12:52:01Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/aprc.000055 2020-06-29 PTZ.APRC:VOL6

The use of aerosolized - Adrenergic agonist therapy after lung transplantation in pediatric age Giorgia GrutterZaccaria Ricci<p>It is my opinion the use of aeresolized –adrenergic agonist such as salbutamol may be helpfull&nbsp; not only&nbsp; to reduced the early mortality but also&nbsp; the chronic allograft dysfunction&nbsp; after lung transplantation in children The reduction of pulmonary&nbsp; edema could be prevent the induction of Obstructive Bronchiolites Syndrome (less pneumonia&nbsp; and viral infections etc) such as the primary graft dysfunction.As we know by international literature Lung transplantation continues to suffer from less-than-ideal long-term outcomes, even in pediatric patients.</p> Archives of Pulmonology and Respiratory Care - Peertechz Publications 2020-06-29 Opinion https://doi.org/10.17352/aprc.000055 en Copyright © Giorgia Grutter et al.